BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 22224978)

  • 1. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.
    Kern W; Bacher U; Haferlach C; Dicker F; Alpermann T; Schnittger S; Haferlach T
    Br J Haematol; 2012 Apr; 157(1):86-96. PubMed ID: 22224978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.
    Rossi D; Sozzi E; Puma A; De Paoli L; Rasi S; Spina V; Gozzetti A; Tassi M; Cencini E; Raspadori D; Pinto V; Bertoni F; Gattei V; Lauria F; Gaidano G; Forconi F
    Br J Haematol; 2009 Jun; 146(1):64-75. PubMed ID: 19438485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G; Kong Y; Yue C
    Cancer Genet Cytogenet; 2010 Jan; 196(1):56-63. PubMed ID: 19963136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
    Reindl L; Bacher U; Dicker F; Alpermann T; Kern W; Schnittger S; Haferlach T; Haferlach C
    Br J Haematol; 2010 Oct; 151(1):25-36. PubMed ID: 20649559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
    Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
    Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
    Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
    Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
    N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.
    Fabris S; Mosca L; Cutrona G; Lionetti M; Agnelli L; Ciceri G; Barbieri M; Maura F; Matis S; Colombo M; Gentile M; Recchia AG; Anna Pesce E; Di Raimondo F; Musolino C; Gobbi M; Di Renzo N; Mauro FR; Brugiatelli M; Ilariucci F; Lipari MG; Angrilli F; Consoli U; Fragasso A; Molica S; Festini G; Vincelli I; Cortelezzi A; Federico M; Morabito F; Ferrarini M; Neri A
    Am J Hematol; 2013 Jan; 88(1):24-31. PubMed ID: 23044996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome study on chronic lymphocytic leukemia using CpG-oligodeoxynucleotide as immunostimulant agent].
    Wu Y; Xue Y; Chen S; Yao L; Jiang H; Zhang J; Shen J; Pan J; Wang Y; Bai S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):86-91. PubMed ID: 20140876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
    Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
    PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukaemia (CLL) and CLL-type monoclonal B-cell lymphocytosis (MBL) show differential expression of molecules involved in lymphoid tissue homing.
    Rawstron AC; Shingles J; de Tute R; Bennett F; Jack AS; Hillmen P
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S42-6. PubMed ID: 20839337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics.
    Nieto WG; Teodosio C; López A; Rodríguez-Caballero A; Romero A; Bárcena P; Gutierrez ML; Langerak AW; Fernandez-Navarro P; Orfao A; Almeida J;
    Cytometry B Clin Cytom; 2010; 78 Suppl 1():S24-34. PubMed ID: 20839335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
    Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR
    Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis.
    Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
    Rawstron AC; Bennett F; Hillmen P
    Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
    Shanafelt TD; Kay NE; Jenkins G; Call TG; Zent CS; Jelinek DF; Morice WG; Boysen J; Zakko L; Schwager S; Slager SL; Hanson CA
    Blood; 2009 Apr; 113(18):4188-96. PubMed ID: 19015397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.